Valproate attenuates the risk of myocardial infarction in patients with epilepsy: a nationwide cohort study
about
Cardiovascular riskStroke genetics: prospects for personalized medicineIs sodium valproate, an HDAC inhibitor, associated with reduced risk of stroke and myocardial infarction? A nested case-control studyRole of histone acetylation in the stimulatory effect of valproic acid on vascular endothelial tissue-type plasminogen activator expressionLate-onset epilepsy and occult cerebrovascular diseaseHistone deacetylase inhibitor treatment increases coronary t-PA release in a porcine ischemia model.Profibrinolytic effect of the epigenetic modifier valproic acid in man.Hormone replacement therapy and risk of new-onset atrial fibrillation after myocardial infarction--a nationwide cohort study.Roles and post-translational regulation of cardiac class IIa histone deacetylase isoforms.Discontinuation of hormone replacement therapy after myocardial infarction and short term risk of adverse cardiovascular events: nationwide cohort studyAntiepileptic drugs and the risk of ischaemic stroke and myocardial infarction: a population-based cohort studyPlaques on the wall: inducing anticonvulsant use and atherogenesis.Risk of ischemic cerebrovascular and coronary events in adult users of anticonvulsant medications in routine care settingsEnzyme induction with antiepileptic drugs: cause for concern?Genetic profiles in ischaemic stroke.Mechanisms and treatment of ischaemic stroke--insights from genetic associations.Epilepsy, excess deaths and years of life lost from external causes.Epilepsy as a systemic condition: Link with somatic comorbidities.The association between dementia and epilepsy: A systematic review and meta-analysis.Postoperative adverse outcomes in surgical patients with epilepsy: a population-based study.Health-related behaviors and comorbidities in people with epilepsy: Changes in the past decade.Illuminating drug action by network integration of disease genes: a case study of myocardial infarction.A reduced risk of stroke with lithium exposure in bipolar disorder: a population-based retrospective cohort study.Trimetazidine potentiates the antiepileptic activity and ameliorates the metabolic changes associated with pentylenetetrazole kindling in rats treated with valproic acid.Sodium Valproate, a Histone Deacetylase Inhibitor, Is Associated With Reduced Stroke Risk After Previous Ischemic Stroke or Transient Ischemic Attack.White Matter Hyperintensities on Brain Magnetic Resonance Imaging in People with Epilepsy: A Hospital-Based Study.Valproic acid selectively increases vascular endothelial tissue-type plasminogen activator production and reduces thrombus formation in the mouse.Dosage of angiotensin-II receptor blockers in heart failure patients following changes in Danish drug reimbursement policies.Effects of epilepsy and selected antiepileptic drugs on risk of myocardial infarction, stroke, and death in patients with or without previous stroke: a nationwide cohort studyDual mechanisms for the regulation of brain-derived neurotrophic factor by valproic acid in neural progenitor cells
P2860
Q26825634-AF3C26EF-253F-459F-B323-DE797355F602Q27006885-E4A43825-0491-4FE3-8959-1468AFBE1C65Q28387103-953351A6-7120-4A28-96E0-D29870D6736EQ28480965-AFD8D84D-A854-4BF0-A800-C3C1B6D981FCQ30755317-304AC46C-11EF-464B-B0A7-FEA666CB8C3BQ33599573-A16C3D37-9AE8-47FD-A47E-8C32B09D8CDAQ34306821-52BE48A5-847B-4CE6-B404-934C97D3869AQ34532001-26C4F474-1D84-4A49-81AE-1B0DADE2DA5AQ35517710-AF5EDA4C-6FB2-42C4-A09E-70BD6AEB6C9BQ35856372-ED870D64-1050-4C2A-9FF1-965BE4F8D9C6Q35960111-242245BC-CD7A-46C6-9839-3724C9C6DB39Q36623450-378F45CA-288B-4ACA-8D84-BAAEB857F687Q37310447-C5BC0149-DA14-4B92-8C9A-AA8E152CDC55Q38046892-FE11B307-9E77-4075-83B6-ECD0D2DAFE50Q38115496-585CDBA0-75CA-4DAF-AC9E-8A5FCE622FACQ38263023-A86805C0-0D4C-4DAF-92A8-432A4123AF9BQ38621227-74F14DF9-28AE-4D42-BC50-F6A76B627F8DQ38749358-581F8E4B-B2B2-4100-8DF5-0CB36BFF44DFQ38842852-DA003C40-E1FB-4EE1-8EEB-0762D6DD1580Q40030836-4E74DCF5-1FF8-4E20-8C95-9CE1D3346F16Q40274156-E9577A2A-62C7-4E79-8B54-AD77CAE2B20CQ40672660-6B2BF2E7-D382-4262-B75F-B3DE255BB974Q41334184-43DCCE12-FCDB-4379-8ABD-107CACFC46F7Q46986264-C576BCB6-BCD4-429E-81A5-892D4D13581DQ47299769-BD193782-7373-4B91-ACB7-3293ACCAFF4AQ48007999-A64A2F5B-B8F9-4E0B-B7F2-7F805B7EB2ACQ48487114-1F99AA6D-5CDE-45C7-9976-247AE83DF4F8Q50561874-D8C0C9C4-3BAF-411A-81A2-F2E3005D6861Q57260384-589CD40F-3763-4915-A238-36EDE13D870BQ58565218-C776D916-561F-40B1-AC70-F149BA854744
P2860
Valproate attenuates the risk of myocardial infarction in patients with epilepsy: a nationwide cohort study
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2010
@uk
name
Valproate attenuates the risk ...... psy: a nationwide cohort study
@en
Valproate attenuates the risk ...... psy: a nationwide cohort study
@nl
type
label
Valproate attenuates the risk ...... psy: a nationwide cohort study
@en
Valproate attenuates the risk ...... psy: a nationwide cohort study
@nl
prefLabel
Valproate attenuates the risk ...... psy: a nationwide cohort study
@en
Valproate attenuates the risk ...... psy: a nationwide cohort study
@nl
P2093
P2860
P50
P356
P1476
Valproate attenuates the risk ...... psy: a nationwide cohort study
@en
P2093
Charlotte Andersson
Michelle Schmiegelow
Peter Weeke
Steen Zabell Abildstrøm
P2860
P304
P356
10.1002/PDS.2073
P577
2010-12-09T00:00:00Z